Reports First Quarter 2026 Financial Results
2026 Annual Meeting Results - Directors Elected at Amneal Pharmaceuticals
Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance
Earnings Release
Material disclosure
Other Events
Amneal Pharmaceuticals Expects to Exceed 2025 Financial Guidance
Reports Third Quarter 2025 Financial Results
Q1
FY 2025
Q3
Q2
FY 2024
Certificate
SEC Form 25 - Delisting Notification
Registration of Securities
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report